ARBINOXA ORAL SOLUTION Rx
Generic Name and Formulations:
Carbinoxamine maleate 4mg/5mL; bubble gum flavor.
Indications for ARBINOXA ORAL SOLUTION:
Allergic (seasonal and perennial) and vasomotor rhinitis, conjunctivitis, urticaria, angioedema, reactions to blood. Adjunct in anaphylaxis. Dermatographism.
4–8mg 3–4 times daily.
<2yrs: contraindicated. 2–5yrs: 0.2–0.4mg/kg/day in 3–4 divided doses. 6–11yrs: 2–4mg 3–4 times daily.
Children <2yrs old. Concomitant MAOIs. Nursing mothers.
Not for treating lower respiratory tract symptoms, including asthma. Narrow angle glaucoma. Peptic ulcer. GI or GU obstruction. Increased intraocular pressure. Hyperthyroidism. Cardiovascular disease. Hypertension. Elderly. Pregnancy (Cat.C).
CNS depression potentiated by alcohol (avoid), other CNS depressants. MAOIs potentiate anticholinergic effects.
Sedation, sleepiness, dizziness, disturbed coordination, GI upset, thickening of bronchial secretions, anticholinergic effects, excitability in children.
Tabs—100; Oral soln—16oz
- New CDC Recommendations for Influenza Vaccination: 2015-2016
- Clinical Suspicion Leads to Uncommon Diagnosis in Patient With High Fever
- Many Pregnant Women Lacking in Element Linked to Cognition in Offspring
- Severe, Persistent Joint Pain Warning Issued for Diabetes Drug Class
- New Insight into Antibiotics-Type 2 Diabetes Link
- Support for PrEP in Clinical Setting, As Study Reports No New HIV Infections
- DEA-Led 'Operation Cyber Juice' to Target Underground Steroid Labs
- Knee, Hip Replacement May Not Have Cardioprotective Effect After All
- Hospitalized Infection Risk for Biologics in RA Compared
- Finerenone Promising for Albuminuria in Diabetic Nephropathy